Medicare Enrolled

Dr. Suong Tran, MD

Rheumatology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1701 SUNSET BLVD, Houston, TX 77005
7135265511
In practice since 2007 (18 years)
NPI: 1851591978 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tran

Dr. Suong Tran is a rheumatology specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Tran performed 53,829 Medicare services across 1,248 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tran received a total of $19,429 from 33 pharmaceutical and/or device companies across 1185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 21% volume in TX $19,429 industry payments

Medicare Practice Summary

Medicare Utilization ↗
53,829
Medicare services
Top 21% in TX for rheumatology
1,248
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,990 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Romosozumab injection (Evenity) for osteoporosis 16,800 $8 $10
Abatacept infusion (Orencia) 13,425 $34 $43
Denosumab injection (Prolia/Xgeva) 9,000 $18 $24
Golimumab infusion (Simponi Aria) 7,703 $10 $13
Infliximab infusion (Remicade) 4,440 $25 $36
Steroid injection (triamcinolone) 518 $1 $1
Drug injection, under skin or into muscle 403 $12 $14
Office visit, established patient (20-29 min) 320 $68 $92
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 317 $52 $65
Office visit, established patient (30-39 min) 224 $94 $130
Administration of chemotherapy into vein, each additional hour 133 $22 $29
Administration of chemotherapy into vein, 1 hour or less 106 $99 $132
Injection, zoledronic acid, 1 mg 90 $6 $8
Joint injection, major joint 68 $57 $85
Aspiration and/or injection of fluid from small joint 59 $46 $67
New patient office visit (45-59 min) 48 $123 $169
Bone density scan (DEXA) 46 $39 $39
Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk 46 $30 $41
New patient office visit (30-44 min) 43 $88 $114
Injection, methylprednisolone sodium succinate, up to 125 mg 24 $4 $6
Injection into tendon or ligament 16 $36 $61
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
48.1% high complexity
50.6% medium
1.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$19,429
Total received (2018-2024)
Avg $2,776/year across 7 years
Top 18% in TX for rheumatology
33
Companies
1,185
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,888 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$541 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,892
2023
$2,310
2022
$1,887
2021
$1,945
2020
$2,906
2019
$3,875
2018
$3,614

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,919
AbbVie Inc.
$2,765
ABBVIE INC.
$1,931
Novartis Pharmaceuticals Corporation
$1,509
E.R. Squibb & Sons, L.L.C.
$1,411
Janssen Biotech, Inc.
$1,212
UCB, Inc.
$1,210
Horizon Therapeutics plc
$1,100
AbbVie, Inc.
$1,004
PFIZER INC.
$657
GENZYME CORPORATION
$566
Lilly USA, LLC
$467
Genentech USA, Inc.
$423
Aurinia Pharma U.S., Inc.
$364
Celgene Corporation
$267
Horizon Pharma plc
$259
Mallinckrodt Enterprises LLC
$237
Mallinckrodt Hospital Products Inc.
$194
GlaxoSmithKline, LLC.
$174
AstraZeneca Pharmaceuticals LP
$162
SANOFI-AVENTIS U.S. LLC
$131
TerSera Therapeutics LLC
$74
Mallinckrodt LLC
$71
MEDEXUS PHARMA, INC.
$67
MEDAC PHARMA, INC.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
West-Ward Pharmaceuticals
$32
Merck Sharp & Dohme Corporation
$30
SOBI, INC
$25
Radius Health, Inc.
$20
Sandoz Inc.
$16
Hikma Pharmaceuticals USA
$15
Antares Pharma, Inc.
$14
Top 3 companies account for 39.2% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · CHANTIX · COSENTYX · Cimzia · DUEXIS · EVENITY · Enbrel · FORTEO · HUMIRA · HYRIMOZ · Humira · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · Prolia · Quzyttir · RAYOS · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · VIMOVO · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $36 per 100 Medicare services performed
Looking for a rheumatology specialist in Houston?
Compare rheumatologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
81
Per 100K population
1.7
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tran is a mixed practice specialist, with above-average Medicare volume (top 21% in TX), with low-engagement industry engagement in the top 18% of TX peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Tran experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Tran performed 16,800 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $19,429 from 33 companies across 1,185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other rheumatologists in Houston?
Dr. Tran's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →